Soru

Zorluk: OrtaEndocrinology and Metabolism

A 48-year-old woman comes to the clinic complaining of progressive fatigue, weight gain of 4 kg (8.8 lb), and cold intolerance over the past 4 months. She also reports that her menstrual periods ceased completely 6 months ago. She has no prior medical history and takes no medications. Her temperature is 36.6°C (97.9°F), blood pressure is 95/60 mmHg, and heart rate is 55/min. Physical examination reveals dry skin, thinning of the lateral eyebrows, and a delayed relaxation phase of the deep tendon reflexes. The thyroid gland is not palpable. Visual field testing is normal.

Laboratory studies show:
Sodium: 133 mEq/L
Potassium: 4.1 mEq/L
Thyroid-stimulating hormone (TSH): 1.1 µU/mL (Normal: 0.4 - 4.0 µU/mL)
Free thyroxine (T4): 0.4 ng/dL (Normal: 0.8 - 1.8 ng/dL)

Which of the following is the most appropriate next step in the management of this patient?

  1. Assessment of serum cortisol and adrenocorticotropic hormone (ACTH) levelsCevap
  2. B
    Initiation of oral levothyroxine therapy
  3. C
    Measurement of anti-thyroid peroxidase antibodies
  4. D
    Reassurance and repeat laboratory testing in 6 weeks
  5. E
    Performance of a radioactive iodine uptake scan

Cevap

Assessment of serum cortisol and adrenocorticotropic hormone (ACTH) levels is required to rule out concomitant central adrenal insufficiency before starting thyroid replacement.
The correct approach requires evaluating the adrenal axis prior to thyroid hormone replacement. This patient's laboratory profile (low free T4 with an inappropriately normal TSH) is the hallmark of central (secondary) hypothyroidism. The accompanying amenorrhea suggests a broader pituitary lesion causing panhypopituitarism. A critical rule in endocrinology is that in patients with suspected panhypopituitarism, adrenal insufficiency must be ruled out (or treated) BEFORE giving thyroid hormone. Levothyroxine increases the basal metabolic rate and hepatic clearance of cortisol; administering it to a patient with undiagnosed central adrenal insufficiency can rapidly precipitate a fatal adrenal crisis.

Adım Adım Çözüm

1
Interpret the thyroid function tests in the context of the clinical presentation.
The patient has a markedly low free T4 but a TSH strictly within the normal range, confirming central (secondary) hypothyroidism rather than primary hypothyroidism.
An intact hypothalamic-pituitary-thyroid axis would respond to a low free T4 with a significantly elevated TSH. An inappropriately normal TSH indicates pituitary or hypothalamic failure.
2
Identify clues suggesting broader anterior pituitary dysfunction.
The patient's recent onset of amenorrhea, combined with central hypothyroidism and borderline low blood pressure and sodium, suggests panhypopituitarism.
Pituitary macroadenomas or other destructive lesions often affect multiple hormone axes simultaneously, notably gonadotropins (FSH/LH) and ACTH.
3
Determine the safest sequence of management.
The adrenal axis must be evaluated (and treated with glucocorticoids if deficient) prior to administering levothyroxine.
Thyroid hormone increases the hepatic clearance of cortisol. If levothyroxine is given to a patient with unrecognized adrenal insufficiency, the sudden drop in circulating cortisol can trigger a fatal adrenal crisis.

Anahtar Kavram

In patients with central hypothyroidism, concurrent central adrenal insufficiency must be ruled out via cortisol/ACTH testing before initiating levothyroxine therapy to prevent precipitating an acute adrenal crisis.
Bu soruyu puanla